Your browser doesn't support javascript.
loading
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020.
Hu, Yu; Pan, Xuejiao; Shen, Linzhi; Chen, Fuxing; Wang, Ying; Liang, Hui; Chen, Yaping; Lv, Huakun.
Afiliação
  • Hu Y; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
  • Pan X; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
  • Shen L; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
  • Chen F; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
  • Wang Y; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
  • Liang H; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
  • Chen Y; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
  • Lv H; Institute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
Hum Vaccin Immunother ; 17(12): 5447-5453, 2021 Dec 02.
Article em En | MEDLINE | ID: mdl-34613883
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / Vacinas contra Papillomavirus Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / Vacinas contra Papillomavirus Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China